• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌及其前体病变中的组蛋白 H3 整体组蛋白修饰。

Global histone modification of histone H3 in colorectal cancer and its precursor lesions.

机构信息

Department of Pathology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi 409-3898, Japan.

出版信息

Hum Pathol. 2012 Jun;43(6):834-42. doi: 10.1016/j.humpath.2011.07.009. Epub 2011 Sep 13.

DOI:10.1016/j.humpath.2011.07.009
PMID:21917293
Abstract

Chromatin remodeling through histone modification is an important mechanism of epigenetic gene dysregulation in human cancers. However, little is known about global alteration of histone status during tumorigenesis and cancer progression. Histone H3 status was examined in benign and malignant colorectal tumors by immunohistochemistry and Western blotting. For immunohistochemical evaluation, 4 anti-histone H3 antibodies, specific to dimethylation at lysine 4 (H3K4me2), acetylation at lysine 9 (H3K9ac), dimethylation at lysine 9 (H3K9me2), and trimethylation at lysine 27 (H3K27me3), were used. On immunohistochemistry, H3K4me2, H3K9ac, and H3K27me3 showed no significant changes between normal and colorectal tumors. On the other hand, the global level of H3K9me2 was distinctly higher in neoplastic cells (adenoma and adenocarcinoma) than in normal glandular cells. In addition, it was significantly higher in adenocarcinoma than in adenoma. Correspondingly, Western blotting confirmed that H3K9me2 expression was significantly higher in adenocarcinomas than in normal colorectal mucosa. No alteration of H3K9me2 was observed with tumor differentiation and with the histological subtypes of colorectal cancers. These results suggest that aberration of the global H3K9me2 level is an important epigenetic event in colorectal tumorigenesis and carcinogenesis involved with gene regulation in neoplastic cells through chromatin remodeling.

摘要

通过组蛋白修饰进行染色质重塑是人类癌症中表观遗传基因失调的重要机制。然而,在肿瘤发生和癌症进展过程中,组蛋白状态的全局变化知之甚少。通过免疫组织化学和 Western blot 检测良性和恶性结直肠肿瘤中的组蛋白 H3 状态。对于免疫组织化学评估,使用了 4 种针对赖氨酸 4 位二甲基化(H3K4me2)、赖氨酸 9 位乙酰化(H3K9ac)、赖氨酸 9 位二甲基化(H3K9me2)和赖氨酸 27 位三甲基化(H3K27me3)的抗组蛋白 H3 抗体。免疫组织化学结果显示,H3K4me2、H3K9ac 和 H3K27me3 在正常和结直肠肿瘤之间没有明显变化。另一方面,H3K9me2 的全局水平在肿瘤细胞(腺瘤和腺癌)中明显高于正常腺细胞。此外,腺癌中的 H3K9me2 水平明显高于腺瘤。相应地,Western blot 证实 H3K9me2 在腺癌中的表达明显高于正常结直肠黏膜。H3K9me2 的改变与肿瘤分化和结直肠癌的组织学亚型无关。这些结果表明,全局 H3K9me2 水平的异常是结直肠肿瘤发生和癌变中的一个重要表观遗传事件,涉及通过染色质重塑调节肿瘤细胞中的基因。

相似文献

1
Global histone modification of histone H3 in colorectal cancer and its precursor lesions.结直肠癌及其前体病变中的组蛋白 H3 整体组蛋白修饰。
Hum Pathol. 2012 Jun;43(6):834-42. doi: 10.1016/j.humpath.2011.07.009. Epub 2011 Sep 13.
2
The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.全球组蛋白修饰模式与结直肠癌异时性肝转移的总生存期相关。
Oncol Rep. 2012 Mar;27(3):637-42. doi: 10.3892/or.2011.1547. Epub 2011 Nov 10.
3
Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma.组蛋白修饰对 AFP 产生的胃腺癌中 GATA4 表达的表观遗传调控。
Exp Mol Pathol. 2012 Aug;93(1):35-9. doi: 10.1016/j.yexmp.2012.03.012. Epub 2012 Mar 24.
4
The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma.全球组蛋白修饰模式与胃腺癌的癌症复发及总生存期相关。
Ann Surg Oncol. 2008 Jul;15(7):1968-76. doi: 10.1245/s10434-008-9927-9. Epub 2008 May 10.
5
Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.全球 H3K27 组蛋白修饰与结直肠癌肝转移患者的预后相关。
Eur J Surg Oncol. 2013 Jun;39(6):655-61. doi: 10.1016/j.ejso.2013.02.023. Epub 2013 Mar 21.
6
Epigenetic signatures and temporal expression of lineage-specific genes in hESCs during differentiation to hepatocytes in vitro.体外诱导人胚胎干细胞向肝细胞分化过程中谱系特异性基因的表观遗传特征和时间表达。
Hum Mol Genet. 2011 Feb 1;20(3):401-12. doi: 10.1093/hmg/ddq476. Epub 2010 Nov 8.
7
Epigenetic modifications induced by RGC-32 in colon cancer.RGC-32 诱导结肠癌发生的表观遗传修饰。
Exp Mol Pathol. 2010 Feb;88(1):67-76. doi: 10.1016/j.yexmp.2009.10.010. Epub 2009 Oct 31.
8
Distinct regulation of histone H3 methylation at lysines 27 and 9 by CpG methylation in Arabidopsis.拟南芥中CpG甲基化对赖氨酸27和9处组蛋白H3甲基化的不同调控
EMBO J. 2005 Aug 3;24(15):2783-91. doi: 10.1038/sj.emboj.7600743. Epub 2005 Jul 7.
9
Expression of p21(WAF1) is related to acetylation of histone H3 in total chromatin in human colorectal cancer.p21(WAF1)的表达与人类结直肠癌总染色质中组蛋白H3的乙酰化有关。
World J Gastroenterol. 2007 Apr 21;13(15):2209-13. doi: 10.3748/wjg.v13.i15.2209.
10
PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.PRDM5被确定为结直肠癌和胃癌中表观遗传沉默的一个靶点。
Clin Cancer Res. 2007 Aug 15;13(16):4786-94. doi: 10.1158/1078-0432.CCR-07-0305.

引用本文的文献

1
The role of physical activity and epigenetic changes in colorectal cancer prevention.体育活动和表观遗传变化在结直肠癌预防中的作用。
Cancer Cell Int. 2025 Jun 22;25(1):227. doi: 10.1186/s12935-025-03872-1.
2
Epigenetic marvels: exploring the landscape of colorectal cancer treatment through cutting-edge epigenetic-based drug strategies.表观遗传学奇迹:通过前沿的基于表观遗传学的药物策略探索结直肠癌治疗前景
Clin Epigenetics. 2025 Feb 22;17(1):34. doi: 10.1186/s13148-025-01844-w.
3
The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy.
组蛋白修饰在肿瘤发生中的作用以及癌症治疗中的相关抑制剂。
J Natl Cancer Cent. 2022 Sep 28;2(4):277-290. doi: 10.1016/j.jncc.2022.09.002. eCollection 2022 Dec.
4
Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis.利用遗传和表观遗传生物标志物检测结直肠癌:筛查和诊断。
J Med Life. 2024 Jan;17(1):4-14. doi: 10.25122/jml-2023-0269.
5
MMP-9-dependent proteolysis of the histone H3 N-terminal tail: a critical epigenetic step in driving oncogenic transcription and colon tumorigenesis.基质金属蛋白酶-9(MMP-9)介导的组蛋白H3 N端尾部蛋白水解:驱动致癌转录和结肠癌发生的关键表观遗传步骤。
Mol Oncol. 2024 Aug;18(8):2001-2019. doi: 10.1002/1878-0261.13652. Epub 2024 Apr 10.
6
Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications.结直肠癌中的表观遗传改变:潜在的诊断和预后意义。
Int J Mol Sci. 2024 Mar 15;25(6):3358. doi: 10.3390/ijms25063358.
7
Pathogenesis and biomarkers of colorectal cancer by epigenetic alteration.表观遗传改变所致结直肠癌的发病机制与生物标志物
Intest Res. 2024 Apr;22(2):131-151. doi: 10.5217/ir.2023.00115. Epub 2024 Feb 1.
8
Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis.探讨结直肠癌转移的潜在表观遗传生物标志物。
Int J Mol Sci. 2024 Jan 10;25(2):874. doi: 10.3390/ijms25020874.
9
From Omic Layers to Personalized Medicine in Colorectal Cancer: The Road Ahead.从奥米克戎分层到结直肠癌的个体化医学:未来之路。
Genes (Basel). 2023 Jul 11;14(7):1430. doi: 10.3390/genes14071430.
10
The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy.EZH2和H3K27me3表达作为涎腺导管癌患者临床预后预测指标的作用:一项着重于与联合雄激素阻断及HER2靶向治疗相关性的大样本研究
Front Oncol. 2022 Feb 3;11:779882. doi: 10.3389/fonc.2021.779882. eCollection 2021.